hu.MAP 3.0: Complex View
Human Protein Complex Map
Search for a protein
Complex: huMAP3_14478.1
Confidence: Medium  
ProteinsGenename | Protein Name | Uniprot Annotation Score | Links |
---|---|---|---|
ASAP1 | Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 (130 kDa phosphatidylinositol 4,5-bisphosphate-dependent ARF1 GTPase-activating protein) (ADP-ribosylation factor-directed GTPase-activating protein 1) (ARF GTPase-activating protein 1) (Development and differentiation-enhancing factor 1) (DEF-1) (Differentiation-enhancing factor 1) (PIP2-dependent ARF1 GAP) | 5 | UniProt   NCBI |
SOS2 | Son of sevenless homolog 2 (SOS-2) | 5 | UniProt   NCBI |
SPATA2L | Spermatogenesis-associated protein 2-like protein (SPATA2-like protein) | 5 | UniProt   NCBI |
THEMIS | Protein THEMIS (Thymocyte-expressed molecule involved in selection) | 5 | UniProt   NCBI |
SPATA2 | Spermatogenesis-associated protein 2 | 5 | UniProt   NCBI |
GAREM1 | GRB2-associated and regulator of MAPK protein 1 (GRB2-associated and regulator of MAPK1) | 5 | UniProt   NCBI |
C16orf96 | Uncharacterized protein C16orf96 | 2 | UniProt   NCBI |
OR6Q1 | Olfactory receptor 6Q1 (Olfactory receptor OR11-226) | 3 | UniProt   NCBI |
PIK3C2B | Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta (PI3K-C2-beta) (PtdIns-3-kinase C2 subunit beta) (EC 2.7.1.137) (EC 2.7.1.154) (C2-PI3K) (Phosphoinositide 3-kinase-C2-beta) | 5 | UniProt   NCBI |
GLS2 | Glutaminase liver isoform, mitochondrial (GLS) (EC 3.5.1.2) (L-glutaminase) (L-glutamine amidohydrolase) | 5 | UniProt   NCBI |
PTPRE | Receptor-type tyrosine-protein phosphatase epsilon (Protein-tyrosine phosphatase epsilon) (R-PTP-epsilon) (EC 3.1.3.48) | 5 | UniProt   NCBI |
SOS1 | Son of sevenless homolog 1 (SOS-1) | 5 | UniProt   NCBI |
NKX2-5 | Homeobox protein Nkx-2.5 (Cardiac-specific homeobox) (Homeobox protein CSX) (Homeobox protein NK-2 homolog E) | 5 | UniProt   NCBI |
GAREM2 | GRB2-associated and regulator of MAPK protein 2 (GRB2-associated and regulator of MAPK1-like) | 3 | UniProt   NCBI |
SHC1 | SHC-transforming protein 1 (SHC-transforming protein 3) (SHC-transforming protein A) (Src homology 2 domain-containing-transforming protein C1) (SH2 domain protein C1) | 5 | UniProt   NCBI |
ALK | ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase) (CD antigen CD246) | 5 | UniProt   NCBI |
ERRFI1 | ERBB receptor feedback inhibitor 1 (Mitogen-inducible gene 6 protein) (MIG-6) | 5 | UniProt   NCBI |
ARHGEF35 | Rho guanine nucleotide exchange factor 35 (Rho guanine nucleotide exchange factor 5-like protein) | 2 | UniProt   NCBI |
ARHGEF5 | Rho guanine nucleotide exchange factor 5 (Ephexin-3) (Guanine nucleotide regulatory protein TIM) (Oncogene TIM) (Transforming immortalized mammary oncogene) (p60 TIM) | 5 | UniProt   NCBI |
GRB2 | Growth factor receptor-bound protein 2 (Adapter protein GRB2) (Protein Ash) (SH2/SH3 adapter GRB2) | 5 | UniProt   NCBI |
CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD (EC 3.4.19.12) (Deubiquitinating enzyme CYLD) (Ubiquitin thioesterase CYLD) (Ubiquitin-specific-processing protease CYLD) | 5 | UniProt   NCBI |
Enrichments
Term ID | Corrected Pval | Fraction Complex Coverage | Proteins | Term Name |
---|---|---|---|---|
  WP:WP4928 | 3.12342042716e-07 | 0.2 | SOS1 SOS2 ALK GAREM2 | MAPK pathway in congenital thyroid cancer |
  WP:WP437 | 3.51970824514e-06 | 0.3 | PIK3C2B GRB2 ERRFI1 SOS1 SOS2 ASAP1 | EGF EGFR signaling pathway |
  REAC:R-HSA-73887 | 4.16541534012e-06 | 0.3 | ARHGEF5 SPATA2 ARHGEF35 CYLD SOS1 SOS2 | Death Receptor Signaling |
  CORUM:6296 | 6.49329465809e-05 | 0.1 | SPATA2 CYLD | SPATA2-CYLD complex |
  CORUM:3144 | 6.49329465809e-05 | 0.1 | SOS1 GRB2 | GRB2-SOS1 complex |
  CORUM:2917 | 6.49329465809e-05 | 0.1 | SOS1 GRB2 | GRB2-SOS1 complex |
  CORUM:2893 | 6.49329465809e-05 | 0.1 | SOS1 GRB2 | BCR-ABL (p210 fusion protein)-GRB2-SOS1 complex |
  REAC:R-HSA-193648 | 9.4434821435e-05 | 0.2 | ARHGEF5 SOS1 SOS2 ARHGEF35 | NRAGE signals death through JNK |
  KEGG:05223 | 0.000117550743137 | 0.2 | SOS1 GRB2 SOS2 ALK | Non-small cell lung cancer |
  WP:WP4205 | 0.000118693518309 | 0.2 | SOS1 GRB2 SOS2 ALK | MET in type 1 papillary renal cell carcinoma |
  REAC:R-HSA-8983432 | 0.000192960242756 | 0.15 | SOS1 SOS2 GRB2 | Interleukin-15 signaling |
  WP:WP4255 | 0.000228301627459 | 0.2 | SOS1 GRB2 SOS2 ALK | Non small cell lung cancer |
  REAC:R-HSA-204998 | 0.000298576862827 | 0.2 | ARHGEF5 SOS1 SOS2 ARHGEF35 | Cell death signalling via NRAGE, NRIF and NADE |
  REAC:R-HSA-416482 | 0.000419813435298 | 0.2 | ARHGEF5 SOS1 SOS2 ARHGEF35 | G alpha (12/13) signalling events |
  CORUM:2922 | 0.000647731199222 | 0.1 | SOS1 GRB2 | LAT-PLC-gamma-1-p85-GRB2-SOS signaling complex, C305 activated |
  WP:WP422 | 0.000774981250946 | 0.15 | SOS1 SOS2 GRB2 | MAPK cascade |
  REAC:R-HSA-193704 | 0.00085684752918 | 0.2 | ARHGEF5 SOS1 SOS2 ARHGEF35 | p75 NTR receptor-mediated signalling |
  WP:WP710 | 0.00118036813175 | 0.2 | SOS1 GRB2 SOS2 PIK3C2B | DNA damage response only ATM dependent |
  CORUM:2480 | 0.00135800282338 | 0.1 | SOS1 GRB2 | CIN85 complex (CIN85, CRK, BCAR1, CBL, PIK3R1, GRB2, SOS1) |
  WP:WP4535 | 0.00221376775043 | 0.15 | SOS1 SOS2 GRB2 | Envelope proteins and their potential roles in EDMD physiopathology |
  KEGG:05206 | 0.00258208802176 | 0.2 | GLS2 GRB2 SOS2 SOS1 | MicroRNAs in cancer |
  KEGG:05213 | 0.00277875027194 | 0.15 | SOS1 SOS2 GRB2 | Endometrial cancer |
  KEGG:04664 | 0.00294290565619 | 0.15 | SOS1 SOS2 GRB2 | Fc epsilon RI signaling pathway |
  WP:WP2253 | 0.00328393756006 | 0.1 | SOS1 GRB2 | Pilocytic astrocytoma |
  REAC:R-HSA-451927 | 0.00361738182966 | 0.15 | SOS1 SOS2 GRB2 | Interleukin-2 family signaling |
  KEGG:05221 | 0.00406263293408 | 0.15 | SOS1 SOS2 GRB2 | Acute myeloid leukemia |
  KEGG:04917 | 0.00471398731322 | 0.15 | SOS1 SOS2 GRB2 | Prolactin signaling pathway |
  KEGG:05211 | 0.00543015768543 | 0.15 | SOS1 SOS2 GRB2 | Renal cell carcinoma |
  KEGG:04662 | 0.0062139700395 | 0.15 | SOS1 SOS2 GRB2 | B cell receptor signaling pathway |
  KEGG:05214 | 0.0062139700395 | 0.15 | SOS1 SOS2 GRB2 | Glioma |
  KEGG:04912 | 0.0062139700395 | 0.15 | SOS1 SOS2 GRB2 | GnRH signaling pathway |
  KEGG:04540 | 0.007068218119 | 0.15 | SOS1 SOS2 GRB2 | Gap junction |
  WP:WP4155 | 0.00755210147677 | 0.15 | SOS1 SOS2 GRB2 | Endometrial cancer |
  KEGG:01521 | 0.00799566364052 | 0.15 | SOS1 SOS2 GRB2 | EGFR tyrosine kinase inhibitor resistance |
  KEGG:05220 | 0.00799566364052 | 0.15 | SOS1 SOS2 GRB2 | Chronic myeloid leukemia |
  WP:WP5293 | 0.0083760456789 | 0.15 | SOS1 SOS2 GRB2 | Acute myeloid leukemia |
  KEGG:04012 | 0.00865597530506 | 0.15 | SOS1 SOS2 GRB2 | ErbB signaling pathway |
  WP:WP4685 | 0.0088091985821 | 0.15 | SOS1 SOS2 GRB2 | Melanoma |
  KEGG:05210 | 0.00935083415945 | 0.15 | SOS1 SOS2 GRB2 | Colorectal cancer |
  KEGG:01522 | 0.0108473666096 | 0.15 | SOS1 SOS2 GRB2 | Endocrine resistance |
  KEGG:05231 | 0.01124432617 | 0.15 | SOS1 SOS2 GRB2 | Choline metabolism in cancer |
  KEGG:05215 | 0.0142895579343 | 0.15 | SOS1 SOS2 GRB2 | Prostate cancer |
  KEGG:04915 | 0.0152481582569 | 0.15 | SOS1 SOS2 GRB2 | Estrogen signaling pathway |
  WP:WP2261 | 0.0185535691025 | 0.15 | GRB2 PIK3C2B ERRFI1 | Glioblastoma signaling pathways |
  KEGG:04935 | 0.0194973343545 | 0.15 | SOS1 SOS2 GRB2 | Growth hormone synthesis, secretion and action |
  KEGG:04722 | 0.0194973343545 | 0.15 | SOS1 SOS2 GRB2 | Neurotrophin signaling pathway |
  WP:WP4806 | 0.0200224081209 | 0.15 | SOS1 SOS2 GRB2 | EGFR tyrosine kinase inhibitor resistance |
  KEGG:04660 | 0.0212684523724 | 0.15 | SOS1 SOS2 GRB2 | T cell receptor signaling pathway |
  WP:WP673 | 0.0215649273898 | 0.15 | SOS1 SOS2 GRB2 | ErbB signaling pathway |
  KEGG:04926 | 0.0244453246516 | 0.15 | SOS1 SOS2 GRB2 | Relaxin signaling pathway |
  KEGG:04650 | 0.0251152500826 | 0.15 | SOS1 SOS2 GRB2 | Natural killer cell mediated cytotoxicity |
  KEGG:04068 | 0.0279130441331 | 0.15 | SOS1 SOS2 GRB2 | FoxO signaling pathway |
  KEGG:04072 | 0.0301378087421 | 0.15 | SOS1 SOS2 GRB2 | Phospholipase D signaling pathway |
  WP:WP4321 | 0.0304389728412 | 0.15 | SOS1 SOS2 GRB2 | Thermogenesis |
  KEGG:04910 | 0.0383675583404 | 0.15 | SOS1 SOS2 GRB2 | Insulin signaling pathway |
  KEGG:05224 | 0.0392615375476 | 0.15 | SOS1 SOS2 GRB2 | Breast cancer |
  REAC:R-HSA-9703648 | 0.0427101208228 | 0.1 | SOS1 GRB2 | Signaling by FLT3 ITD and TKD mutants |
  REAC:R-HSA-428540 | 0.0427101208228 | 0.1 | SOS1 SOS2 | Activation of RAC1 |
  KEGG:05160 | 0.0429706405059 | 0.15 | SOS1 SOS2 GRB2 | Hepatitis C |
  KEGG:04630 | 0.0429706405059 | 0.15 | SOS1 SOS2 GRB2 | JAK-STAT signaling pathway |
  KEGG:05226 | 0.0429706405059 | 0.15 | SOS1 SOS2 GRB2 | Gastric cancer |
  KEGG:04217 | 0.0489426466655 | 0.15 | SPATA2L CYLD SPATA2 | Necroptosis |
  WP:WP581 | 0.0499126318911 | 0.1 | SOS1 GRB2 | EPO receptor signaling |
  CORUM:2895 | 0.0499436884912 | 0.05 | GRB2 | SHC-GRB2 complex |
  CORUM:3096 | 0.0499436884912 | 0.05 | GRB2 | ITGA6-ITGB4-SHC1-GRB2 complex |
  CORUM:2892 | 0.0499436884912 | 0.05 | GRB2 | BCR-ABL (p185 fusion protein)-GRB2 complex |
  CORUM:2540 | 0.0499436884912 | 0.05 | GRB2 | BCR-ABL (p210 fusion protein)-GRB2 complex |
Edges
Protein 1 | Protein 2 | Score | ProteomeHD |
---|---|---|---|
 SOS2 |  GRB2 | 1.0 | 0.192           |
 GRB2 |  ASAP1 | 0.999 | 0.066           |
 GRB2 |  SOS1 | 0.999 | 0.134           |
 GRB2 |  GAREM1 | 0.999 |            |
 GAREM2 |  GAREM1 | 0.998 |            |
 ERRFI1 |  GRB2 | 0.998 | 0.202           |
 GAREM1 |  OR6Q1 | 0.997 |            |
 ARHGEF35 |  ARHGEF5 | 0.994 |            |
 GRB2 |  CYLD | 0.994 | 0.263837209302           |
 SHC1 |  GAREM1 | 0.988 |            |
 GRB2 |  GAREM2 | 0.985 |            |
 GRB2 |  PTPRE | 0.982 | 0.212           |
 SHC1 |  GRB2 | 0.976 |            |
 GLS2 |  GRB2 | 0.974 | 0.2           |
 C16orf96 |  GRB2 | 0.968 |            |
 ARHGEF35 |  GRB2 | 0.965 |            |
 NKX2-5 |  GRB2 | 0.955 |            |
 ARHGEF5 |  GRB2 | 0.954 | 0.134           |
 GRB2 |  SPATA2L | 0.948 |            |
 GRB2 |  SPATA2 | 0.923 | 0.132           |
 PIK3C2B |  GRB2 | 0.908 | 0.130726027397           |
 SOS2 |  ARHGEF35 | 0.904 |            |
 ERRFI1 |  ARHGEF35 | 0.904 |            |
 SOS2 |  PTPRE | 0.904 | 0.088           |
 GAREM2 |  OR6Q1 | 0.902 |            |
 ARHGEF35 |  PTPRE | 0.902 |            |
 GRB2 |  THEMIS | 0.901 | 0.19           |
 SOS2 |  ASAP1 | 0.9 | 0.058           |
 ARHGEF35 |  SOS1 | 0.892 |            |
 SHC1 |  OR6Q1 | 0.892 |            |
 SOS1 |  PTPRE | 0.892 | 0.112           |
 ASAP1 |  SOS1 | 0.883 | 0.152           |
 SOS2 |  SOS1 | 0.877 | 0.118           |
 SOS2 |  ARHGEF5 | 0.869 | 0.092           |
 SOS2 |  ERRFI1 | 0.844 | 0.09           |
 SHC1 |  ALK | 0.827 |            |
 SHC1 |  GAREM2 | 0.796 |            |
 ARHGEF5 |  SOS1 | 0.768 | 0.138           |
 ARHGEF35 |  ASAP1 | 0.768 |            |
 ERRFI1 |  ASAP1 | 0.73 | 0.098           |
 ERRFI1 |  SOS1 | 0.73 | 0.116           |
 ERRFI1 |  PTPRE | 0.722 | 0.11           |
 SHC1 |  ARHGEF35 | 0.715 |            |
 ARHGEF5 |  PTPRE | 0.676 | 0.094           |
 SHC1 |  SOS1 | 0.675 |            |
 SHC1 |  SOS2 | 0.675 |            |
 ERRFI1 |  ARHGEF5 | 0.626 | 0.15           |
 C16orf96 |  SOS2 | 0.557 |            |
 C16orf96 |  ERRFI1 | 0.557 |            |
 C16orf96 |  SPATA2L | 0.557 |            |
 C16orf96 |  GAREM2 | 0.557 |            |
 GAREM2 |  SPATA2L | 0.557 |            |
 C16orf96 |  GAREM1 | 0.543 |            |
 PIK3C2B |  C16orf96 | 0.502 |            |
 GAREM1 |  SPATA2L | 0.502 |            |
 C16orf96 |  CYLD | 0.502 |            |
 C16orf96 |  ASAP1 | 0.502 |            |
 C16orf96 |  SPATA2 | 0.502 |            |
 SOS2 |  GAREM2 | 0.487 |            |
 C16orf96 |  SOS1 | 0.487 |            |
 ERRFI1 |  SPATA2L | 0.487 |            |
 SOS2 |  SPATA2L | 0.487 |            |
 ERRFI1 |  GAREM2 | 0.487 |            |
 ASAP1 |  PTPRE | 0.478 | 0.056           |
 SHC1 |  PTPRE | 0.401 |            |
 ARHGEF5 |  ASAP1 | 0.388 | 0.084           |
 PIK3C2B |  ERRFI1 | 0.387 | 0.092           |
 GRB2 |  OR6Q1 | 0.377 |            |
 CYLD |  SPATA2 | 0.366 | 0.088           |
 GAREM2 |  SPATA2 | 0.35 |            |
 NKX2-5 |  C16orf96 | 0.35 |            |
 SHC1 |  ASAP1 | 0.343 |            |
 SHC1 |  ERRFI1 | 0.343 |            |
 SOS1 |  SPATA2L | 0.337 |            |
 SOS1 |  GAREM2 | 0.337 |            |
 ASAP1 |  SPATA2L | 0.333 |            |
 CYLD |  GAREM2 | 0.333 |            |
 ASAP1 |  GAREM2 | 0.333 |            |
 SHC1 |  ARHGEF5 | 0.331 |            |
 ERRFI1 |  GAREM1 | 0.33 |            |
 PIK3C2B |  GAREM2 | 0.303 |            |
 SOS2 |  GAREM1 | 0.303 |            |
 SPATA2 |  SPATA2L | 0.287 |            |
 ERRFI1 |  CYLD | 0.265 | 0.03           |
 NKX2-5 |  ASAP1 | 0.262 |            |
 C16orf96 |  PTPRE | 0.214 |            |
 ARHGEF35 |  SPATA2L | 0.214 |            |
 C16orf96 |  ARHGEF5 | 0.214 |            |
 PTPRE |  SPATA2L | 0.214 |            |
 ARHGEF5 |  SPATA2L | 0.214 |            |
 ARHGEF5 |  GAREM2 | 0.214 |            |
 GAREM2 |  PTPRE | 0.214 |            |
 C16orf96 |  ARHGEF35 | 0.214 |            |
 ARHGEF35 |  GAREM2 | 0.214 |            |
 PIK3C2B |  SPATA2L | 0.213 |            |
 CYLD |  GAREM1 | 0.191 |            |
 PIK3C2B |  GAREM1 | 0.191 |            |
 NKX2-5 |  PIK3C2B | 0.189 |            |
 ASAP1 |  CYLD | 0.176 | 0.132           |
 CYLD |  SPATA2L | 0.173 |            |
 SOS2 |  SPATA2 | 0.172 | 0.102           |
 NKX2-5 |  GAREM2 | 0.172 |            |
 SOS1 |  SPATA2 | 0.172 | 0.156           |
 SOS1 |  CYLD | 0.172 | 0.162           |
 ERRFI1 |  SPATA2 | 0.172 | 0.082           |
 SOS2 |  CYLD | 0.172 | 0.162           |
 NKX2-5 |  SPATA2L | 0.172 |            |
 NKX2-5 |  SPATA2 | 0.164 |            |
 ASAP1 |  SPATA2 | 0.164 | 0.09           |
 ASAP1 |  GAREM1 | 0.164 |            |
 PIK3C2B |  SOS1 | 0.164 | 0.12           |
 NKX2-5 |  SOS1 | 0.164 |            |
 PIK3C2B |  SOS2 | 0.164 | 0.084           |
 NKX2-5 |  CYLD | 0.164 |            |
 GAREM1 |  SPATA2 | 0.164 |            |
 SOS1 |  GAREM1 | 0.164 |            |
 PIK3C2B |  ASAP1 | 0.164 | 0.052           |
 NKX2-5 |  SOS2 | 0.164 |            |
 NKX2-5 |  ERRFI1 | 0.164 |            |
 NKX2-5 |  GAREM1 | 0.143 |            |
 ARHGEF35 |  GAREM1 | 0.131 |            |
 SHC1 |  C16orf96 | 0.131 |            |
 GAREM1 |  PTPRE | 0.131 |            |
 PTPRE |  SPATA2 | 0.131 | 0.076           |
 ARHGEF35 |  SPATA2 | 0.128 |            |
 GLS2 |  SPATA2L | 0.122 |            |
 GLS2 |  GAREM2 | 0.122 |            |
 C16orf96 |  GLS2 | 0.122 |            |
 PIK3C2B |  GLS2 | 0.11 | 0.168           |
 NKX2-5 |  GLS2 | 0.11 |            |
 GLS2 |  CYLD | 0.11 | 0.09           |
 GLS2 |  SOS1 | 0.11 | 0.062           |
 ERRFI1 |  GLS2 | 0.11 | 0.066           |
 SOS2 |  GLS2 | 0.11 | 0.154           |
 GLS2 |  ASAP1 | 0.11 | 0.092           |
 GLS2 |  GAREM1 | 0.11 |            |
 GLS2 |  SPATA2 | 0.11 | 0.092           |
 ARHGEF5 |  GAREM1 | 0.1 |            |
 PIK3C2B |  CYLD | 0.082 | 0.174           |
 PIK3C2B |  ARHGEF5 | 0.07 | 0.148           |
 ARHGEF5 |  SPATA2 | 0.07 | 0.098           |
 CYLD |  PTPRE | 0.055 | 0.138           |
 PIK3C2B |  ARHGEF35 | 0.046 |            |
 NKX2-5 |  ARHGEF35 | 0.046 |            |
 PIK3C2B |  PTPRE | 0.046 | 0.076           |
 NKX2-5 |  PTPRE | 0.046 |            |
 PIK3C2B |  SHC1 | 0.044 |            |
 NKX2-5 |  ARHGEF5 | 0.043 |            |
 NKX2-5 |  SHC1 | 0.042 |            |
 ARHGEF5 |  CYLD | 0.039 | 0.246           |
 PIK3C2B |  SPATA2 | 0.038 | 0.098           |
 GRB2 |  ALK | 0.027 |            |
 SHC1 |  SPATA2L | 0.025 |            |
 ARHGEF35 |  CYLD | 0.025 |            |
 SHC1 |  CYLD | 0.022 |            |
 SHC1 |  SPATA2 | 0.016 |            |
 ARHGEF5 |  GLS2 | 0.015 | 0.104           |
 ARHGEF35 |  GLS2 | 0.015 |            |
 GLS2 |  PTPRE | 0.015 | 0.072           |
 SHC1 |  GLS2 | 0.013 |            |
 ALK |  SPATA2 | 0.012 |            |
 CYLD |  ALK | 0.008 |            |
Related Complexes